Ischemic injury of the heart is associated with activation of multiple signal transduction systems including the heterotrimeric G-protein system. Here, we report a role of the ischemia-inducible regulator of G␥ subunit, AGS8, in survival of cardiomyocytes under hypoxia. Cultured rat neonatal cardiomyocytes (NCM) were exposed to hypoxia or hypoxia/ reoxygenation following transfection of AGS8siRNA or pcDNA::AGS8. Hypoxia-induced apoptosis of NCM was completely blocked by AGS8siRNA, whereas overexpression of AGS8 increased apoptosis. AGS8 formed complexes with G-proteins and channel protein connexin 43 (CX43), which regulates the permeability of small molecules under hypoxic stress. AGS8 initiated CX43 phosphorylation in a G␥-dependent manner by providing a scaffold composed of G␥ and CX43. AGS8siRNA blocked internalization of CX43 following exposure of NCM to repetitive hypoxia; however it did not influence epidermal growth factor-mediated internalization of CX43. The decreased dye flux through CX43 that occurred with hypoxic stress was also prevented by AGS8siRNA. Interestingly, the G␥ inhibitor Gallein mimicked the effect of AGS8 knockdown on both the CX43 internalization and the changes in cell permeability elicited by hypoxic stress. These data indicate that AGS8 is required for hypoxia-induced apoptosis of NCM, and that AGS8-G␥ signal input increased the sensitivity of cells to hypoxic stress by influencing CX43 regulation and associated cell permeability. Under hypoxic stress, this unrecognized response program plays a critical role in the fate of NCM. G-protein-coupled receptors (GPCRs)4 are signaling proteins on the cell surface responsible for mediating various ligands, such as hormones and neurotransmitters. Activation of cell surface GPCRs initiates nucleotide exchange on G␣ subunits, which leads to a conformational change of G␣␥ and subsequent transduction of signals to various intracellular effector molecules (1-3). In addition to such established signaling pathways, recent studies indicate the existence of a novel class of regulatory proteins for heterotrimeric G-proteins. These regulatory proteins may provide alternative signal processing via G␣␥, G␣, or G␥ subunits distinct from typical GPCR pathways, and identifying these mechanisms may uncover unrecognized roles of G-proteins beyond simple transducers of signals from GPCRs (4 -6).During the alteration of signaling pathways in disease states, such regulatory proteins may be involved in adaptation programs of cells to maintain homeostasis (7-11). Genetic modification of regulatory proteins for G-proteins leads to the development of cardiovascular dysfunction in mice including hypertension, maladaptive response to pressure overload, or altered baroreceptor reflex (9, 12, 13). Thus, such regulatory accessory proteins may be involved in the development of disease via either regulating GPCR-initiated signals or by undefined, alternative G-protein signaling pathways operating independent of the receptor.In our efforts to adaptation-specific sig...
We have demonstrated that chronic stimulation of the prostaglandin E 2 -cAMP-dependent protein kinase A (PKA) signal pathway plays a critical role in intimal cushion formation in perinatal ductus arteriosus (DA) through promoting synthesis of hyaluronan. We hypothesized that Epac, a newly identified effector of cAMP, may play a role in intimal cushion formation (ICF) in the DA distinct from that of PKA. In the present study, we found that the levels of Epac1 and Epac2 mRNAs were significantly up-regulated in the rat DA during the perinatal period. A specific EP4 agonist, ONO-AE1-329, Prostaglandin E 2 (PGE 2 )3 is the most potent vasodilatory lipid mediator in the ductus arteriosus (DA), a fetal arterial connection between the pulmonary artery and the descending aorta (1). PGE 2 increases the intracellular concentration of cAMP, which activates cAMP-dependent protein kinase A (PKA), resulting in vasodilation in the DA (1, 2). In addition to its vasodilatory effect, our recent study has identified that chronic PGE 2 stimulation has another essential effect on DA development, namely intimal cushion formation (ICF) (3). Briefly, via EP4, a predominant PGE 2 receptor in the DA, the PGE 2 -cAMP-PKA stimulation up-regulates hyaluronic acid (HA) synthases, which increases HA production. Accumulation of HA then promotes smooth muscle cell (SMC) migration into the subendothelial layer to form intimal thickening. ICF then leads to luminal narrowing, helping adhesive occlusion of the vascular lumen and thus complete anatomical closure of the DA.A new target of cAMP, i.e. an exchange protein activated by cAMP, has recently been discovered; it is called Epac (4).
The ductus arteriosus (DA), a fetal arterial connection between the pulmonary artery and the aorta, has a character distinct from the adjacent arteries. We compared the transcriptional profiles of the DA and the aorta of Wistar rat fetuses on embryonic day 19 (preterm) and day 21 (near-term) using DNA microarray analyses. We found that 39 genes were expressed 2.5-fold greater in the DA than in the aorta. Growth hormone (GH) receptor (GHR) exhibited the most significant difference in expression. Then, we found that GH significantly promoted migration of DA smooth muscle cells (SMCs), thus enhancing the intimal cushion formation of the DA explants. GH also regulated the expression of cytoskeletal genes in DA SMCs, which may retain a synthetic phenotype in the smooth muscle-specific cytoskeletal genes. Thus, the present study revealed that GH-GHR signal played a role in the vascular remodeling of the DA.
The ductus arteriosus (DA), an essential vascular shunt for fetal circulation, begins to close immediately after birth. Although Ca 2؉ influx through several membrane Ca 2؉ channels is known to regulate vasoconstriction of the DA, the role of the T-type voltage-dependent Ca 2؉ channel (VDCC) in DA closure remains unclear. Here we found that the expression of ␣1G, a T-type isoform that is known to exhibit a tissue-restricted expression pattern in the rat neonatal DA, was significantly upregulated in oxygenated rat DA tissues and smooth muscle cells (SMCs). Immunohistological analysis revealed that ␣1G was localized predominantly in the central core of neonatal DA at birth. DA SMC migration was significantly increased by ␣1G overexpression. Moreover, it was decreased by adding ␣1G-specific small interfering RNAs or using R(؊)-efonidipine, a highly selective T-type VDCC blocker. Furthermore, an oxygenationmediated increase in an intracellular Ca 2؉ concentration of DA SMCs was significantly decreased by adding ␣1G-specific siRNAs or using R(؊)-efonidipine. The ductus arteriosus (DA) 2 is an essential vascular shunt between the aortic arch and the pulmonary trunk during a fetal period (1). After birth, the DA closes immediately in accordance with its smooth muscle contraction and vascular remodeling, whereas the connecting vessels such as the aorta and pulmonary arteries remain open. When the DA fails to close after birth, the condition is known as patent DA, which is a common form of congenital heart defect. Patent DA is also a frequent problem with significant morbidity and mortality in premature infants. Investigating the molecular mechanism of DA closure is important not only for vascular biology but also for clinical problems in pediatrics.Voltage-dependent Ca 2ϩ channels (VDCCs) consist of multiple subtypes, named L-, N-, P/Q-, R-, and T-type. L-type VDCCs are known to play a primary role in regulating Ca 2ϩ influx and thus vascular tone in the development of arterial smooth muscle including the DA (2-4). Our previous study demonstrated that all T-type VDCCs were expressed in the rat DA (5). ␣1G subunit, especially, was the most dominant isoform among T-type VDCCs. The abundant expression of ␣1G subunit suggests that it plays a role in the vasoconstriction and vascular remodeling of the DA. In this regard, Nakanishi
This method allows repeated, direct access to the immobilized muscle, making it a useful procedure for concurrent application and assessment of various therapeutic interventions. Muscle Nerve 54: 788-791, 2016.
Energy of the cardiac muscle largely depends on fatty acid oxidation. It is known that the atrium and ventricle have chamber-specific functions, structures, gene expressions, and pathologies. The left ventricle works as a high-pressure chamber to pump blood toward the body, and its muscle wall is thicker than those of the other chambers, suggesting that energy utilization in each of the chambers should be different. However, a chamber-specific pattern of metabolism remains incompletely understood. Recently, innovative techniques have enabled the comprehensive analysis of metabolites. Therefore, we aimed to clarify differences in metabolic patterns among the chambers. Male C57BL6 mice at 6 wk old were subject to a comprehensive measurement of metabolites in the atria and ventricles by capillary electrophoresis and mass spectrometry. We found that overall metabolic profiles, including nucleotides and amino acids, were similar between the right and left ventricles. On the other hand, the atria exhibited a distinct metabolic pattern from those of the ventricles. Importantly, the high-energy phosphate pool (the total concentration of ATP, ADP, and AMP) was higher in both ventricles. In addition, the levels of lactate, acetyl CoA, and tricarboxylic acid cycle contents were higher in the ventricles. Accordingly, the activities and/or expression levels of key enzymes were higher in the ventricles to produce more energy. The present study provides a basis for understanding the chamber-specific metabolism underlining pathophysiology in the heart.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.